Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat

Laboratory Investigation

Volumn 76, Issue 6, 1997, Pages 765-778

  Desmoulière, Alexis ^a   Darby, Ian ^d   Costa, Andréa Monte Alto ^a   Raccurt, Mireille ^a   Tuchweber, Beatriz ^b   Sommer, Pascal ^a   Gabbiani, Giulio ^c  

^a INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; ELASTIN; FIBRONECTIN; LAMININ; MESSENGER RNA; PROCOLLAGEN; PROTEIN LYSINE 6 OXIDASE; SCLEROPROTEIN; TENASCIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL DIFFERENTIATION; CHOLESTATIC HEPATITIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; LIVER FIBROSIS; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTINS; ANIMALS; CELL DIFFERENTIATION; CHOLESTASIS; CHOLESTASIS, EXTRAHEPATIC; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MICROSCOPY, IMMUNOELECTRON; MUSCLE, SMOOTH; PROTEIN-LYSINE 6-OXIDASE; RATS; RATS, WISTAR;

EID: 0030947446     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Abdel-Aziz G, Rescan PY, Clément B, Lebeau G, Rissel M, Grimaud JA, Campion JP, and Guillouzo A (1991). Cellular sources of matrix proteins in experimentally induced cholestatic rat liver. J Pathol 164:167-174.
2. Almassian B, Trackman PC, Iguchi H, Boak A, Calvaresi D, and Kagan HM (1991). Induction of lysyl oxidase activity and lysyl oxidase protein by exposure of rats to cadmium chloride: Properties of the induced enzyme. Connect Tissue Res 25:197-208.
3. Arora PD and McCulloch CAG (1994). Dependence of collagen remodeling on α-smooth muscle actin expression by fibroblasts. J Cell Physiol 159:161-175.
4. Baccarini-Contri M, Vincenzi D, Quaglino D Jr, Mori G, and Pasquali-Ronchetti I (1989). Localization of lysyl oxidase on human placenta, skin, and aorta by immunoelectron microscopy. Matrix 9:428-436.
5. Boak AM, Roy R, Berk J, Taylor L, Polgar P, Goldstein RH, and Kagan HM (1994). Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor-β1 and prostaglandin E2. Am J Respir Cell Mol Biol 11:751-755.
6. Border WA and Noble NA (1994). Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286-1292.
7. Borsi L, Carnemolla B, Castellani P, Rosellini C, Vecchio D, Allemanni G, Chang SE, Taylor-Papadimitriou J, Pande H, and Zardi L (1987). Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J Cell Biol 104:595-600.
8. Borsi L, Castellani P, Risso AM, Leprini A, and Zardi L (1990). Transforming growth factor-β regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett 261: 175-178.
9. Charbonneau M, Tuchweber B, and Plaa GL (1986). Acetone potentiation of chronic liver injury induced by repetitive administration of carbon tetrachloride. Hepatology 6:694-700.
10. Chichester CO, Palmer KC, Hayes JA, and Kagan HM (1981). Lung lysyl oxidase and prolyl hydroxylase: Increases induced by cadmium chloride inhalation and the effect of β-aminopropionitrile in rats. Am Rev Respir Dis 124:709-713.
11. Clément B, Emonard H, Rissel M, Druget M, Grimaud JA, Herbage D, Bourel M, and Guillouzo A (1984). Cellular origin of collagen and fibronectin in the liver. Cell Mol Biol (Noisyle-grand) 30:489-496.
12. Clément B, Loréal O, Rescan PY, Levavasseur F, Diakonova M, Rissel M, L'Helgoualc'h, and Guillouzo A (1992). Cellular origin of the hepatic extracellular matrix. In: Gressner AM and Ramadori G, editors: Molecular and cell biology of liver fibrogenesis. Dordrecht: Kluwer Academic Publishers, 85-98.
13. Clément B, Rissel M, Peyrol S, Mazurier Y, Grimaud JA, and Guillouzo A (1985). A procedure for light and electron microscopic intracellular immunolocalization of collagen and fibronectin in rat liver. J Histochem Cytochem 33:407-414.
14. Constantine VS and Mowry RW (1968). Selective staining of human dermal collagen: Part II - The use of Picrosirius Red F3BA with polarization microscopy. J Invest Dermatol 50: 419-423.
15. Counts DF, Evans JN, Dipetrillo TA, Sterling KM Jr, and Kelley J (1981). Collagen lysyl oxidase activity in the lung increases during bleomycin-induced lung fibrosis. J Pharmacol Exp Ther 219:675-678.
16. Darby I, Skalli O, and Gabbiani G (1990). α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63:21-29.
17. Desmoulière A, Geinoz A, Gabbiani F, and Gabbiani G (1993). Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103-111.
18. Edwards DR, Murphy G, Reynolds JJ, Whitman SE, Docherty AJP, Angel P, and Heath JK (1987). Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1906.
19. Friedman SL (1993). The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328: 1828-1835.
20. Fushidatakemura H, Fukuda M, Maekawa N, Chanoki M, Kobayashi H, Yashiro N, Ishii M, Hamada T, Otani S, and Ooshima A (1996). Detection of lysyl oxidase gene expression in rat skin during wound healing. Arch Dermatol Res 288:7-10.
21. Genovese C, Rowe D, and Kream B (1984). Construction of DNA sequences complementary to rat α1 and α2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry 23:6210-6216.
22. Ingber DE (1993). Cellular tensegrity: Defining new rules of biological design that govern the cytoskeleton. J Cell Sci 104:613-627.
23. Iredale JP, Benyon RC, Arthur MJP, Ferris WF, Alcolado R, Winwood PJ, Clark N, and Murphy G (1996). Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 24:176-184.
24. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, and Bissell DM (1994). Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 127: 2037-2048.
25. Kagan HM and Trackman PC (1991). Properties and function of lysyl oxidase. Am J Respir Cell Mol Biol 5:206-210.
26. Kagan HM, Vaccaro CA, Bronson RE, Tang S, and Brody JS (1986). Ultrastructural immunolocalization of lysyl oxidase in vascular connective tissue. J Cell Biol 103:1121-1128.
27. Kim Y, Boyd CD, and Csiszar K (1995). A new gene with sequence and structural similarities to the gene encoding human lysyl oxidase. J Biol Chem 270:7176-7182.
28. Kontouras J, Billing BH, and Scheuer PJ (1984). Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat. Br J Exp Pathol 65:305-311.
29. Lennette DA (1978). An improved mounting medium for immunofluorescent microscopy. Am J Cln Pathol 69:647-648.
30. Martinez-Hernandez A and Amenta PS (1995). The extracellular matrix in hepatic regeneration. FASEB J 9:1401-1410.
31. Miyazaki H, Van Eyken P, Roskams T, De Vos R, and Desmet VJ (1993). Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: An immunohistochemical study. J Hepatol 19:353-366.
32. Pérez Tamayo R (1983). Is cirrhosis of the liver experimentally produced by CCI4 an adequate model of human cirrhosis? Hepatology 3:112-120.
33. Porto LC, Chevallier M, Guerret S, Hartmann DJ, and Grimaud JA (1990). Elastin in alcoholic liver disease. An immunohistochemical and immunoelectron microscopy study. Pathol Res Pract 186:668-679.
34. Ramadori G, Veit T, Schwögler S, Dienes HP, Knittel T, Rieder H, and Meyer KH (1990). Expression of the gene of α-smooth muscle-actin isoform in rat liver and in rat fat-storing (Ito) cells. Virchows Arch B Cell Pathol 59:349-357.
35. Rockey DC, Boyles JK, Gabbiani G, and Friedman SL (1992). Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 24:193-203.
36. Schmitt-Gräff A, Krüger S, Bochard F, Gabbiani G, and Denk H (1991). Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased humans livers. Am J Pathol 138:1233-1242.
37. Siegel RC, Chen KH, Greenspan JS, and Aguiar JM (1978). Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat. Proc Natl Acad Sci U S A 75:2945-2949.
38. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, and Gabbiani G (1986). A monoclonal antibody against α-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 103:2787-2796.
39. Slott PA, Liu MH, and Tavoloni N (1990). Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in rat. Gastroenterology 99:466-477.
40. Sommer P, Gleyzal C, Raccurt M, Delbourg M, Serrar M, Joazeiro P, Peyrol S, Kagan H, Trackman PC, and Grimaud JA (1993). Transient expression of lysyl oxidase by liver myofibroblasts in murine schistosomiasis. Lab Invest 69: 460-470.
41. Tomasek JJ, Haaksma CJ, Eddy RJ, and Vaughan MB (1992). Fibroblast contraction occurs on release of tension in attached collagen lattices: Dependency of an organized actin cytoskeleton and serum. Anat Rec 232:359-368.
42. Tuchweber B, Desmoulière A, Bochaton-Piallat ML, Rubbia-Brandt L, and Gabbiani G (1996). Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest 74:1-14.
43. Wakasaki H and Ooshima A (1990). Immunohistochemical localization of lysyl oxidase with monoclonal antibodies. Lab Invest 63:377-384.